JP2023541606A5 - - Google Patents

Info

Publication number
JP2023541606A5
JP2023541606A5 JP2023516137A JP2023516137A JP2023541606A5 JP 2023541606 A5 JP2023541606 A5 JP 2023541606A5 JP 2023516137 A JP2023516137 A JP 2023516137A JP 2023516137 A JP2023516137 A JP 2023516137A JP 2023541606 A5 JP2023541606 A5 JP 2023541606A5
Authority
JP
Japan
Application number
JP2023516137A
Other languages
Japanese (ja)
Other versions
JPWO2022056378A5 (https=
JP2023541606A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/050064 external-priority patent/WO2022056378A1/en
Publication of JP2023541606A publication Critical patent/JP2023541606A/ja
Publication of JPWO2022056378A5 publication Critical patent/JPWO2022056378A5/ja
Publication of JP2023541606A5 publication Critical patent/JP2023541606A5/ja
Pending legal-status Critical Current

Links

JP2023516137A 2020-09-11 2021-09-13 腎臓を保護しながらがんを治療するための方法 Pending JP2023541606A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062706829P 2020-09-11 2020-09-11
US62/706,829 2020-09-11
US202163158803P 2021-03-09 2021-03-09
US63/158,803 2021-03-09
PCT/US2021/050064 WO2022056378A1 (en) 2020-09-11 2021-09-13 Method for treating cancer with kidney protection

Publications (3)

Publication Number Publication Date
JP2023541606A JP2023541606A (ja) 2023-10-03
JPWO2022056378A5 JPWO2022056378A5 (https=) 2024-09-20
JP2023541606A5 true JP2023541606A5 (https=) 2024-09-20

Family

ID=80626052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023516137A Pending JP2023541606A (ja) 2020-09-11 2021-09-13 腎臓を保護しながらがんを治療するための方法

Country Status (10)

Country Link
US (1) US20220079984A1 (https=)
EP (1) EP4210691A4 (https=)
JP (1) JP2023541606A (https=)
KR (1) KR20230112608A (https=)
CN (1) CN116348107A (https=)
AU (1) AU2021342291A1 (https=)
CA (1) CA3192411A1 (https=)
IL (1) IL301305A (https=)
MX (1) MX2023002929A (https=)
WO (1) WO2022056378A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118103047A (zh) 2021-08-27 2024-05-28 美国瑞根特有限公司 铁组合物及其制备和使用方法
JPWO2024253189A1 (https=) * 2023-06-09 2024-12-12

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651758B2 (en) * 1992-02-07 1994-07-28 Tsumura & Co. Side-effect alleviant
AU6010696A (en) * 1995-06-10 1997-01-09 Vitra Pharmaceuticals Ltd Iron compounds, compositions, methods of making the same and uses thereof
WO2005094202A2 (en) * 2004-03-16 2005-10-13 Navinta, Llc Iron sucrose complexes and method of manufacture thereof
DK2262520T3 (en) * 2008-02-26 2017-08-07 Univ Cornell COMPOSITIONS FOR PREVENTION AND TREATMENT OF Kidney Injury
SI3200582T1 (sl) * 2014-09-29 2024-04-30 Fred Hutchinson Cancer Center Sestave, kompleti in metode za indukcijo pridobljene citorezistence z uporabo induktorjev stresnih proteinov
AU2016366668A1 (en) * 2015-12-11 2018-05-31 Fred Hutchinson Cancer Research Center Peptides for renal therapy
CN119488480A (zh) * 2019-02-28 2025-02-21 雷尼布斯治疗公司 新型铁组合物及其制造和使用方法

Similar Documents

Publication Publication Date Title
JP2022522009A5 (https=)
JP2023541606A5 (https=)
CN306346237S (https=)
CN305546084S (https=)
CN306188122S (https=)
CN306186320S (https=)
CN306182557S (https=)
CN305537382S (https=)
CN305537353S (https=)
CN305536965S (https=)
CN305769037S (https=)
CN305536422S (https=)
CN305536339S (https=)
CN305534766S (https=)
CN305534369S (https=)
CN305532306S (https=)
CN305531957S (https=)
CN305530111S (https=)
CN305529651S (https=)
CN305529090S (https=)
CN306352899S (https=)
CN306348407S (https=)
CN306347795S (https=)
CN306347328S (https=)
CN306181335S (https=)